Clinical Trials for Systemic Amyloidosis

Find clinical trials for systemic amyloidosis. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

NCT ID: NCT06342466

This clinical trial is studying a combination of three medications—bortezomib, pomalidomide, and dexamethasone—aimed at treating patients with newly diagnosed systemic light chain (AL) amyloidosis,...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Amyloidosis Incidence in High-Risk Cardiac Device Patients

NCT ID: NCT06186167

This clinical trial is looking into how to better diagnose cardiac amyloidosis, a condition where abnormal proteins build up in the heart and can cause serious health issues. The study will focus o...

Recruiting

Type: observational Locations: Overland Park, Kansas, United States

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

NCT ID: NCT05951816

This clinical trial is looking at a new imaging agent called 99mTc-p5+14, which is designed to help doctors detect amyloid deposits in the body. Amyloidosis is a condition where abnormal proteins b...

Recruiting

Phase: PHASE1 Type: interventional Locations: Knoxville, Tennessee, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions